Acne, hyperandrogenism, and resistance to oral isotretinoin: 23 case reports. Therapeutical outcomes;Acne, hyperandrogenie et resistance l'isotretinoine orale: 23 cas. Implications therapeutiques

Annales de Dermatologie et de Venereologie

Volumn 124, Issue 10, 1997, Pages 692-695

  Lehucher Ceyrac, D ^a   Chaspoux, C ^a   Weber, M J ^a   Morel, P ^a   Vexiau, R ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE ACETATE; ISOTRETINOIN; KERATOLYTIC AGENT;

ACNE; ADRENAL GLAND; ADULT; ALOPECIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HYPERANDROGENISM; MALE; ORAL DRUG ADMINISTRATION; OVARY; TREATMENT FAILURE; ACNE VULGARIS; ADOLESCENT; DRUG RESISTANCE; MIDDLE AGED;

ACNE VULGARIS; ADOLESCENT; ADULT; DRUG RESISTANCE; FEMALE; HUMANS; HYPERANDROGENISM; ISOTRETINOIN; KERATOLYTIC AGENTS; MIDDLE AGED; TREATMENT FAILURE;

EID: 0030663932     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Straus J.S., Rapini R.P., Shalita A.R., Konecki E., Pochi P.E., Comite H., Exner J.H. Isotretinoin for acne: results of a multicenter dose-response study. J Am Acad Dermatol, 1984;10:490-6.
2. Jones D.H., Cunliffe W.J. Remission rates in acne patients treated with various doses of 13-cis-retinoic acid. Br J Dermatol, 1984;111:123-5.
3. Harms M., Masouyé I., Radeff B. The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study. Dermatologica, 1986;172:148-53.
4. Lehucher-Ceyrac D., Weber-Buisset M.J. Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology, 1993;186:123-8
5. Burke B.M., Cunliffe W.J. The assessment of acne vulgaris: the Leeds technique. Br J Dermatol, 1984;111:83-92.
6. Vcxiau P., Boudou P., Brérault J.-L., Villette J.-M., Julien R., Cathelineau G., Fiet J. Hyperandrogénie clinique et stérilité. Immunol Anal Biol Spéc, 1990;22:35-40.
7. Lucky A.W. Hormonal correlates of acne and hirsutism. Am J Med, 1995;98:89-94.
8. Pugeat M. Anti-androgènes disponibles pour le traitement de l'hyperandrogénie cutanée. Rev Fr Gynécol Obstet. 1989;84:505-8.
9. Vexiau P., Gueux B., Vexiau-Robert D., Fiet J., Laureaux C., Tabuteau F. et al. Metabolic effects of combined cyproterone acetate and percutaneous 17 B estradiol after six and twelve month therapy in 61 patients. Horm Metab Res, 1988;20:765-9.